
Neoctide 0.05mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Octreotide acetate (0.05mg)
Overview Neoctide 0.05mg Injection
Octreotide 0.05mg injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, and helps prevent post-pancreatic surgery complications. Administration is exclusively by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your physician. Consistent use maximizes therapeutic effect; discontinue only under medical supervision. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications you are currently using.
Uses of Neoctide 0.05mg Injection
Overgrowth from acromegaly, carcinoid cancers, and bleeding esophageal varices.
Major Benefits of Neoctide 0.05mg Injection:
Administering this medication will be done by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Neoctide 0.05mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Neoctide 0.05mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Neoctide 0.05mg Injection works:
Neoctide 0.05mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator that suppresses the activity of several hormones, including growth hormone. Its vasoconstrictive properties also reduce esophageal bleeding by narrowing blood vessels in the affected area.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Neoctide 0.05mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Administration of Neoctide 0.05mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Neoctide 0.05mg Injection while breastfeeding appears to be unlikely to cause harm. Available data from human studies indicate minimal risk to the infant.
DrivingSAFE
Administering a 0.05mg Neoctide injection typically has no impact on driving capabilities.
KidneySAFE IF PRESCRIBED
Neoctide 0.05mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Administering Neoctide 0.05mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification for Neoctide 0.05mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Neoctide 0.05mg Injection :
Should you forget a dose of Neoctide 0.05mg Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Neoctide 0.05mg Injection
| Label | Value |
|---|---|
| Chemical Category | Somatostatin Receptor Ligands |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Behavioral Class | Somatostatin analogs |
